Thursday 9 April, 2009

Budesonide Respules (Pulmicort) inhalation suspension: AstraZeneca sued Apotex to seek a declaration of patent infringement

In continuation of our earlier post on Budesonide Here, Innovator Astra announced ( in a press release Here) that Astra has filed a lawsuit in the US District Court for the District of New Jersey against Apotex (Apotex) seeking a declaration of patent infringement
Also, Innovator has filed a motion for Interim Relief seeking to prohibit sales of Apotex’s generic product until the patent infringement case has concluded. The Court has indicated that it will hear oral arguments regarding the motion on 16 April 2009.

No comments:

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker